| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| William Enright | Chief Executive Officer, Director | $1.78M | Jan 2, 2024 | ||
| Geoffrey Lynn | Chief Scientific Officer | $1.56M | Dec 17, 2024 | ||
| Robin Wright | Director | $118K | May 10, 2024 | ||
| Joseph Scheeren | Director | $56.1K | May 10, 2024 | ||
| Leon Hooftman | Chief Medical Officer | Jun 3, 2024 | |||
| Karen A. Dawes | Director | May 10, 2024 | |||
| Alex Hammacher | Director | May 10, 2024 | |||
| Graham Griffiths | Chief Business Officer | Jan 2, 2024 | |||
| Gemma Brown | Chief Financial Officer | Jan 2, 2024 | |||
| Nadege Pelletier | Chief Scientific Officer | Jan 2, 2024 | |||
| Pierre A. Morgon | Director | May 10, 2024 | |||
| Anne M. Phillips | Director | May 10, 2024 | |||
| M&G Alternatives Investment Management Ltd | 10%+ Owner | Sep 30, 2022 | |||
| M&G Investment Management Ltd | 10%+ Owner | Sep 30, 2022 | |||
| Thomas George Evans | Fmr Chief Scientific Officer | Jan 3, 2023 | |||
| Georgy Egorov | Chief Financial Officer | Jan 3, 2022 | |||
| Christopher Ellis | Chief Operating Officer | Jan 3, 2023 | |||
| Margaret Marshall | Chief Medical Officer | Jan 3, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|